Memantine and cholelithiasis Patient Reports February 12, 2012

Memantine Side Effects Report #4953062-7
Memantine side effect was reported by a Pharmacist from FRANCE on Mar 02, 2006. Female patient, 92 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: cholelithiasis, hepatic function abnormal. Memantine dosage: unknown. During the same period patient was treated with ALDALIX, CORVASAL, STILNOX, TIAPRIDAL. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5391702-1
Memantine side effect was reported by a Health Professional from GERMANY on July 02, 2007. Male patient, 90 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: c-reactive protein increased, chest pain , cholecystitis, cholelithiasis, condition aggravated, heart rate increased, pyrexia. Memantine dosage: unknown. During the same period patient was treated with DONEPEZIL, AMBROXOL HYDROCHLORIDE, SENNA LEAF, RANITIDINE HYDROCHLORIDE, TEPRENONE, URSODESOYXCHOLIC ACID, MIDODRINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5404755-9
Memantine side effect was reported by a Health Professional from JAPAN on July 24, 2007. Male patient, 90 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: cholecystitis, cholelithiasis, heart rate increased. Memantine dosage: unknown. During the same period patient was treated with DONEPEZIL, AMBROXOL HYDROCHLORIDE, SENNA LEAF, RANITIDINE HYDROCHLORIDE, TEPRENONE, URSODESOXYCHOLIC ACID. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5642287-3
Memantine side effect was reported by a Consumer or non-health professional from JAPAN on July 24, 2007. Male patient, 90 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: blood albumin decreased, chest pain , cholecystitis, cholelithiasis, depressed mood, disease recurrence, heart rate increased, pyrexia. Memantine dosage: unknown. During the same period patient was treated with DONEPEZIL, AMBROXOL HYDROCHLORIDE, SIENNA LEAF, RANITIDINE HYDROCHLORIDE, TEPRENONE, URSODESOXYCHOLIC ACID. Patient was hospitalized. Patient recovered.


Memantine Side Effects Report #5810795-8
Memantine side effect was reported by a Consumer or non-health professional from JAPAN on June 30, 2008. Male patient, 90 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: chest pain , cholecystitis, cholelithiasis, disease recurrence, heart rate increased. Memantine dosage: 20 MG QD PO. During the same period patient was treated with DONEPEZIL, AMBROXOL HYDROCHLORIDE, SENNA LEAF, RANITIDINE HYDROCHLORIDE, TEPRENONE, URSODESOXYCHOLIC ACID. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5500275-1
Memantine side effect was reported by a Health Professional from JAPAN on Oct 11, 2007. Female patient, 88 years of age, weighting 90.39 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: bacterial infection , bile duct stone, biliary tract infection, cholelithiasis, gallbladder disorder, hepatic cyst, hepatic lesion, liver abscess, restlessness. Memantine dosage: unknown. During the same period patient was treated with BROTIZOLAM, AMLODIPINE BESYLATE, VALSARTAN, FELBINAC. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5705223-7
Memantine side effect was reported by a Health Professional from JAPAN on Apr 04, 2008. Female patient, 88 years of age, weighting 90.39 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: bacterial infection , biliary tract disorder, biliary tract infection, cholelithiasis, dementia , gallbladder enlargement, hepatic cyst, inflammation, liver abscess. Memantine dosage: 20 MG QD PO. During the same period patient was treated with BROTIZOLAM, AMLODIPINE BESILATE, VALSARTAN, FELBINAC. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5832246-X
Memantine side effect was reported by a Consumer or non-health professional from GERMANY on July 22, 2008. Female patient, 84 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: blood glucose increased, blood urea increased, carbohydrate antigen 19-9 increased, cholecystitis, cholelithiasis, enteritis infectious, femoral neck fracture, pneumonia , pneumonia aspiration. Memantine dosage: 20 MG (20 MG,1 IN 1 D), ORAL. During the same period patient was treated with DONEPEZIL HYDROCHLORIDE, PROPIVERINE, ANTIBIOTIC, MAGNESIUM OXIDE, TRIMEBUTINE, GLYBURIDE. Patient was hospitalized. Patient died on 01/19/2008.

Memantine Side Effects Report #5901380-8
Memantine side effect was reported by a Consumer or non-health professional from GERMANY on Sept 17, 2008. Female patient, 84 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: blood glucose increased, blood potassium decreased, blood triglycerides increased, cholecystitis, cholelithiasis, enteritis infectious, femoral neck fracture, pneumonia , pneumonia aspiration. Memantine dosage: 20 MG (20 MG, 1 IN 1 D) ,ORAL. During the same period patient was treated with DONEPEZIL HYDROCHLORIDE, PROPIVERINE HYDROCHLORIDE, ANTIBIOTIC, MAGNESIUM OXIDE, TRIMEBUTINE, GLYBURIDE. Patient was hospitalized. Patient died on 01/19/2008.


Memantine Side Effects Report #5327313-3
Memantine side effect was reported by a Physician from UNITED STATES on May 03, 2007. Male patient, 80 years of age, weighting 175.0 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: acute prerenal failure, blood calcium decreased, blood potassium decreased, blood pressure increased, cholelithiasis, haematocrit decreased, haemoglobin decreased, incisional hernia, pancreatitis acute. Memantine dosage: 28 MG QD PO. During the same period patient was treated with ATENOLOL, POTASSIUM CHLORIDE, ARICEPT, GEODON, LASIX, ASPIRIN, LISINOPRIL, SENOKOT. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5336613-2
Memantine side effect was reported by a Physician from UNITED STATES on May 14, 2007. Male patient, 80 years of age, weighting 175.0 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: acute prerenal failure, blood pressure increased, cholelithiasis, dehydration, haematocrit decreased, haemoglobin decreased, pancreatitis acute. Memantine dosage: 28 MG QD PO. During the same period patient was treated with ATENOLOL, POTASSIUM CHLORIDE, ARICEPT, GEODON, LASIX, ASPIRIN, LISNIOPRIL, SENOKOT. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #4724496-0
Memantine side effect was reported by a Consumer or non-health professional from JAPAN on July 08, 2005. Male patient, 74 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood pressure increased, blood urea increased, body temperature increased, cholangitis, cholecystitis, cholelithiasis, depressed level of consciousness, grip strength decreased. Memantine dosage: 20 MG QD PO. During the same period patient was treated with SULPIRIDE, TOCOPHEROL NICOTINATE, BROTIZOLAM. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5451099-5
Memantine side effect was reported by a Health Professional from GERMANY on Aug 23, 2007. Male patient, 70 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: cholelithiasis, pancreatitis. Memantine dosage: 10 MG BID PO. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5512350-6
Memantine side effect was reported by a Health Professional from GERMANY on Oct 26, 2007. Male patient, 70 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: cholelithiasis, pancreatitis. Memantine dosage: 10 MG BID PO. Patient was hospitalized. Patient recovered.


Memantine Side Effects Report #4561107-1
Memantine side effect was reported by a Health Professional from on Jan 13, 2005. Male patient, 67 years of age, weighting 158.0 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: anxiety , blood cholesterol increased, chest pain , cholelithiasis, colitis, coronary artery atherosclerosis, coronary artery occlusion, depression , diverticulitis. Memantine dosage: 20 MG QD PO. During the same period patient was treated with METRONIDAZOLE. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5077910-8
Memantine side effect was reported by a Consumer or non-health professional from SPAIN on July 21, 2006. Male patient, 66 years of age, weighting 136.7 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: cholelithiasis, pancreatitis. Memantine dosage: 20 MG QD PO. During the same period patient was treated with RISPERDAL, LORAZEPAM. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5119996-8
Memantine side effect was reported by a Health Professional from SPAIN on Sept 01, 2006. Male patient, 66 years of age, weighting 136.7 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: cholelithiasis, pancreatitis. Memantine dosage: 20 MG QD PO. During the same period patient was treated with RISPERDAL, LORAZEPAM. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5130095-1
Memantine side effect was reported by a Health Professional from GERMANY on Oct 11, 2006. Male patient, 66 years of age, weighting 136.7 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: cholelithiasis, pancreatitis. Memantine dosage: 20 MG QD PO. During the same period patient was treated with RISPERDAL, LORAZEPAM. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5158779-X
Memantine side effect was reported by a Health Professional from SPAIN on Nov 01, 2006. Male patient, 66 years of age, weighting 136.7 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: cholelithiasis, pancreatitis. Memantine dosage: 20 MG QD PO. During the same period patient was treated with RISPERDAL, LORAZEPAM. Patient was hospitalized. Patient recovered.


Memantine Side Effects Report #4970340-6
Memantine side effect was reported by a Health Professional from FRANCE on Mar 22, 2006. Female patient, 92 years of age, weighting 121.3 lb, was diagnosed with dementia , insomnia, agitation and was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anti-hbs antibody positive, aspartate aminotransferase increased, biliary dilatation, blood alkaline phosphatase increased, c-reactive protein increased, cholelithiasis, gallbladder disorder, gamma-glutamyltransferase increased. Memantine dosage: 10 MG BID PO. During the same period patient was treated with STILNOX, ALDALIX, CORVASAL, TIAPRIDAL. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #4984242-2
Memantine side effect was reported by a Consumer or non-health professional from FRANCE on Apr 18, 2006. Female patient, 92 years of age, weighting 121.3 lb, was diagnosed with dementia , insomnia, agitation and was treated with Memantine. After drug was administered, patient experienced the following side effects: anti-hbs antibody positive, c-reactive protein increased, cholelithiasis, hepatitis a antibody positive. Memantine dosage: 10 MG BID PO. During the same period patient was treated with ZOLPIDEM TARTRATE, TIAPRIDAL, ALDALIX, CORVASAL. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5148144-3
Memantine side effect was reported by a Consumer or non-health professional from SPAIN on Nov 01, 2006. Male patient, 66 years of age, weighting 136.7 lb, was treated with Memantine. After drug was administered, patient experienced the following side effects: cholelithiasis, pancreatitis. Memantine dosage: 20 MG QD PO. During the same period patient was treated with RISPERDAL, LORAZEPAM. Patient was hospitalized. Patient recovered.